Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Romulo Colindres
Age : 50
Country of residence : Unknown
Linked companies : GlaxoSmithKline plc - Vaxcyte, Inc.

Biography of Romulo Colindres 
Dr. Romulo Colindres is a Chief Medical Officer at Vaxcyte, Inc. and a VP-Global Medical Affairs Lead for Zoster at GlaxoSmithKline Plc. He is on the Board of Directors at Ovoca Bio Plc. He received his graduate degree from Unc Gillings School of Global Public Health, an MBA from The Fuqua School of Business and a doctorate degree from UNC School of Medicine.


Current positions of Romulo Colindres 
Romulo Colindres : Personal Network 
Most Read News 
01/04ELON MUSK : Musk-backed Starlink to refund pre-orders in India after govt order
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/07RICHARD BRANSON : British tycoon Branson to list blank-check firm in Amsterdam, Sky News says
RE
01/07TIM COOK : Tim Cook earned over 1,400 times the average Apple worker in 2021
RE
More news


© 2022 People and Ownership :   
Romulo Colindres : Connections 


Latest news about Romulo Colindres 
2021Ovoca Bio plc Announces Resignation of Romulo Colindres as Non-Executive Director
CI
2020VAXCYTE : Posts Smaller-Than-Expected Q3 Loss
MT
2018Ovoca Gold plc Announces Change of Directors
CI
More news